FIBROGEN
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. The company applies its pioneering expertise in hypoxia-inducible factor (HIF), connective tissue growth factor (CTGF) biology, and clinical development to advance innovative medicines for the treatment of anemia, fibrotic disease, and cancer. FibroGe... n's product Roxadustat is an oral small-molecule inhibitor of HIF prolyl hydroxylase activity in worldwide Phase 3 clinical development for the treatment of anemia in chronic kidney disease (CKD), with a New Drug Application currently under review in China by the State Drug Administration or SDA (formerly the China Food and Drug Administration).
FIBROGEN
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
1993-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.fibrogen.com
Total Employee:
251+
Status:
Active
Contact:
415-978-1200
Email Addresses:
[email protected]
Total Funding:
188.02 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Sitelinks Search Box IPv6 Google Maps GStatic Google Static Content
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
AstraZeneca
AstraZeneca investment in Post-IPO Equity - FibroGen
Apothecary Capital
Apothecary Capital investment in Venture Round - FibroGen
Sigma Capital Group
Sigma Capital Group investment in Venture Round - FibroGen
Astellas Pharma
Astellas Pharma investment in Venture Round - FibroGen
BioFund Management
BioFund Management investment in Venture Round - FibroGen
Corriente Biotechnology Partners
Corriente Biotechnology Partners investment in Venture Round - FibroGen
Adage Capital Management
Adage Capital Management investment in Venture Round - FibroGen
Duquesne Capital Management
Duquesne Capital Management investment in Venture Round - FibroGen
Rosewood Corporation
Rosewood Corporation investment in Venture Round - FibroGen
T. Rowe Price
T. Rowe Price investment in Venture Round - FibroGen
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2021-08-16 | FibroGen Announces Retirement of Pat Cotroneo and Appointment of Juan Graham as Chief Financial Officer |
Official Site Inspections
http://www.fibrogen.com Semrush global rank: 1.82 M Semrush visits lastest month: 12.44 K
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "FibroGen"
FibroGen, Inc. Management Team | Org Chart - RocketReach
FibroGen, Inc. employs 420 employees. The FibroGen, Inc. management team includes Mike Martinelli (Senior Vice President), Tricia Stewart (Chief People Officer), and Michael …See details»
FibroGen - Crunchbase Company Profile & Funding
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet …See details»
Executive Team - FibroGen
Supported by a staff of approximately 300 employees worldwide, we are focused on delivering first-in-class medicines for the treatment of unmet medical needs. Senior Vice President, Regulatory, Biometrics, Scientific Communications, …See details»
Org Chart Fibrogen - The Official Board
Organizational Chart of Fibrogen. Fibrogen www.fibrogen.com. has 19 executives +1 415 978 1200; Add an executive. Fibrogen (FGEN) News . Anything missing? We search for you. Print …See details»
FibroGen, Inc. (FGEN) Company Profile & Facts - Yahoo Finance
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.See details»
ESG - FibroGen
At FibroGen, we have embraced a corporate vision statement across our enterprise: Our mission is to improve the lives of people globally by developing innovative therapies anchored in high …See details»
FibroGen - Overview, News & Similar companies | ZoomInfo.com
May 6, 2024 View FibroGen (www.fibrogen.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
FibroGen - The Org
FibroGen, Inc. is a science-based biopharmaceutical company discovering and developing a pipeline of first- in-class therapeutics.See details»
FibroGen, Inc. Company Profile | San Francisco, CA | Competitors ...
Company Description: FibroGen is a biopharmaceutical company focused on accelerating the development of novel therapies at the frontiers of cancer biology and anemia. The company is …See details»
FibroGen - Devex
FibroGen, Inc. is a leading science-based biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics.See details»
FibroGen, Inc. - LinkedIn
We are committed to discovering, developing, and commercializing a pipeline of first-in-class therapeutics to change the lives of people globally. We are also committed to being a place …See details»
FibroGen, Inc. Corporate Presentation
Roxadustat: The Leader in Oral HIF-PHI Anemia Therapeutics Anemia in CKD Patients • U.S./EU • Positive efficacy topline results from all Phase 3 studies supporting U.S. NDA and EU MAA • …See details»
FibroGen Company Profile 2024: Stock Performance & Earnings
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company …See details»
Contact the Board | FibroGen, Inc.
You can contact FibroGen, Inc.'s Board of Directors or an individual FibroGen director to provide comments, to report concerns, or to ask a question, at the following address: Corporate …See details»
FibroGen, Inc. Corporate Presentation
3. FibroGen internal estimates 4. Takehara et al. Cells (2022), 11, 143; Belhassen et al. Respir Res (2021) 22:135; Corral et al. BMC Pulmonary Medicine (2020) 20:188 Progressive Disease …See details»
FibroGen, Inc. (FGEN) - Yahoo Finance Canada
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are …See details»
Our Culture - FibroGen
At FibroGen, we offer a comprehensive benefits program to help our employees thrive in all areas of life. We offer competitive, high-quality support programs that enable you to do your very …See details»
Press Releases - FibroGen, Inc.
Jun 3, 2024 FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 Targeting Monoclonal Antibody, for the Treatment of Patients with Solid …See details»
Our Expertise - FibroGen
At the core of our focus, lies a deep understanding of the complexities that govern central mediators and internal pathways in the field of oncology. In the complex landscape of …See details»